A new study by Mayo Clinic Comprehensive Cancer Center researchers found that the presence of a specific genetic ...

Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept ...

The small study in patients with a rare disorder that causes liver and lung damage showed the potential for precisely ...

Early research shows a one-time gene therapy has potential for addressing both the liver and lung disease that patients with ...

Researchers are conducting a groundbreaking trial that could revolutionize the way the body fights cancer, particularly for ...

Scientists are sounding alarms about a genetic mutation that was recently identified in four dairy cow herds, nearly one year ...

This surge reflects the increasing reliance on genetic diagnostics for identifying hereditary diseases, guiding cancer ...

Beam Therapeutics reported promising Phase 1/2 data for BEAM-302, demonstrating durable gene correction for AATD. See why I am upgrading BEAM.

BEAM-302 "has set the bar for efficacy in this space," William Blair analysts wrote in an investor note on Monday.